Characterizing the invasion of different breast cancer cell lines with distinct E-cadherin status in 3D using a microfluidic system by Eslami Amirabadi, H. (H.) et al.
Characterizing the invasion of different breast cancer cell lines
with distinct E-cadherin status in 3D using a microfluidic system
H. Eslami Amirabadi1,2,3 & M. Tuerlings1,4 & A. Hollestelle5 & S. SahebAli1 & R. Luttge1 & C. C. van Donkelaar4 &
J. W. M. Martens5 & J. M. J. den Toonder1
# The Author(s) 2019
Abstract
E-cadherin is a cell-cell adhesion protein that plays a prominent role in cancer invasion. Inactivation of E-cadherin in breast
cancer can arise from gene promoter hypermethylation or genetic mutation. Depending on their E-cadherin status, breast cancer
cells adopt different morphologies with distinct invasion modes. The tumor microenvironment (TME) can also affect the cell
morphology and invasion mode. In this paper, we used a previously developed microfluidic system to quantify the three-
dimensional invasion of breast cancer cells with different E-cadherin status, namely MCF-7, CAMA-1 and MDA-MB-231 with
wild type, mutated and promoter hypermethylated E-cadherin, respectively. The cells migrated into a stable and reproducible
microfibrous polycaprolactone mesh in the chip under a programmed stable chemotactic gradient. We observed that the MDA-
MB-231 cells invaded the most, as single cells. MCF-7 cells collectively invaded into the matrix more than CAMA-1 cells,
maintaining their E-cadherin expression. The CAMA-1 cells exhibited multicellular multifocal infiltration into the matrix. These
results are consistent with what is seen in vivo in the cancer biology literature. In addition, comparison between complete serum
and serum gradient conditions showed that the MDA-MB-231 cells invaded more under the serum gradient after one day,
however this behavior was inverted after 3 days. The results showcase that the microfluidic system can be used to quantitatively
assess the invasion behavior of cancer cells with different E-cadherin expression, for a longer period than conventional invasion
models. In the future, it can be used to quantitatively investigate effects of matrix structure and cell treatments on cancer invasion.
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1 Introduction
Breast cancer is the most frequent type of cancer in women
and one of the two leading causes of cancer deaths worldwide
(Ferlay et al. 2012). The mortality rate escalates in advanced
stages of the cancer where cancer cells have entered the cir-
culation and disseminate throughout the body. This process is
called metastasis and causes 90% of cancer-associated deaths.
In the first step of metastasis, cancer invasion, cancer cells
invade locally into the surrounding of the tumor. Cancer cells
invade with two major invasion modes (or patterns): single
cell migration with no or poor contact between cancer cells,
and collective migration in groups of cells where cancer cells
maintain their cell-cell adhesion (Friedl and Alexander 2011).
One of the prominent cell-cell adhesion proteins that can af-
fect the cancer cell invasion mode is E-cadherin (Rodriguez
et al. 2012). Loss of E-cadherin is traditionally associated with
enhanced cancer invasion and promoting single cell invasion
(Berx and van Roy 2009), but the expression of E-cadherin
can also facilitate multicellular invasion in cancers with
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epithelial phenotype (Friedl and Gilmour 2009). Expression
of E-cadherin in breast cancer can be abolished in two ways:
by genetic inactivation due to genetic aberrations (mostly due
to mutations), and by gene promoter hypermethylation
(Hollestelle et al. 2013). Cells from these two categories have
distinct morphologies, which are also different from the cells
with wild type E-cadherin. Breast cancer cells with E-
cadherin mutation have a rounded morphology, a diffuse
growth pattern, and invade in a multicellular organization
(Khalil et al. 2017). Breast cancer cells with hypermethylated
E-cadherin gene promoter adopt spindle like morphology and
often have markers of epithelial mesenchymal transition
(EMT), a global epigenetic/differentiation program through
which cancer cells gain the ability to invade and metastasize
(Graff et al. 1995; Lombaerts et al. 2006). Breast cancers with
the wild type E-cadherin, on the other hand, maintain cell-cell
contact and show a collective invasion pattern with an epithe-
lial cell morphology (Cheung and Ewald 2014).
In addition to the E-cadherin status of the cells, the tumor
microenvironment (TME) can change the invasion pattern in
breast cancers (Friedl and Alexander 2011). The TME in breast
cancer consists of cellular and non-cellular components which
continuously interact with the tumor (Quail and Joyce 2013).
Among them, the extracellular matrix (ECM) is a fibrous net-
work of proteins that provides the invading cancer cells with
both biophysical and biochemical cues. In addition, soluble
gradients of chemokines or growth factors exist in the TME.
These gradients together with the remodeled ECM in the TME
direct cancer cells to invade, a process called chemotaxis
(Roussos et al. 2011). In vitro invasion models must recapitu-
late essential components of the TME in order to capture the
invasion mode. Conventional in vitro models used to compare
the invasion of cancer cells often do not include these compo-
nents. For example, conventional Transwell and wound healing
assays lack the 3D environment of the ECM as well as the
possibility to maintain stable biochemical gradients around
the cancer cells (Van Horssen et al. 2012; Justus et al. 2014).
Moreover, a systematic study to compare the three-dimensional
invasion pattern of breast cancer cells is still missing from the
literature. To address these shortcomings, microfluidic chips are
emerging since their flexible design and laminar flow allow
biologists to generate a 3D cell culture with a controlled gradi-
ent around the cells (Polacheck et al. 2013;Wu et al. 2013). It is
challenging to realize these factors in an open culture system
(Sleeboom et al. 2018). Most microfluidic chips use injectable
hydrogels to mimic the 3D ECM. However, hydrogels have
disadvantages; they offer only limited possibilities to create a
well-controlled fibrous matrix structure, often show low me-
chanical stability over time, and do not allow retrieval from
the chip for post-analysis. As an alternative to hydrogels, we
have previously developed a microfabrication method to inte-
grate engineered and mechanically more stable 3D matrices
inside microfluidic chips (Eslami Amirabadi et al. 2017).
In the present study, we applied our previously developed
microfabrication method to realize microfluidic chips with a
thick integrated polycaprolactone (PCL) electrospun fibrous
matrix, to quantitatively compare the invasion of three breast
cancer cell lines with distinct E-cadherin status in 3D. We
used a perfusion system to create a serum gradient (as a
chemoattractant) around the cancer cells during the experi-
ments. We used MCF-7, CAMA-1 and MDA-MB-231 cells
with wild type E-cadherin, in-frame E-cadherinmutation and
hypermethylated E-cadherin promoter, respectively. CAMA-
1 cells do not express functional E-cadherin and MDA-MB-
231 cells completely lack E-cadherin expression, whereas
MCF-7 cells express functional E-cadherin. We first charac-
terized the microfluidic system and also E-cadherin expres-
sion on the matrix. After culturing the cells inside the
microfluidic chip, we found that, after 1 day, the MDA-MB-
231 cells invaded more in the presence of gradient than in a
positive control condition where the serum is available every-
where. After 3 days, this was inverted and the cells invaded
more in the positive control. Moreover, MDA-MB-231 cells
showed a uniform single cell migration pattern and invaded
deeper into the matrix after 3 days compared to CAMA-1 and
MCF-7. CAMA-1 cells invaded into the matrix mostly with a
multicellular pattern, and showed the multifocal behavior seen
in lobular breast cancers. MCF-7 cells invaded into the 3D
matrix in a collective mode maintaining cell-cell contact.
These results are consistent with what is generally known
from the cancer biology literature (Cheung and Ewald 2014;
Graff et al. 1995; Khalil et al. 2017; Lombaerts et al. 2006),
and they show that our system is able to quantitatively capture
the invasion ability and the invasion mode of the breast cancer
cell lines in an engineered fibrous 3D microenvironment, un-
der controlled conditions. Hence it forms a major advance-
ment over 2D assays like the Transwell or wound healing
assays, and it is a viable alternative to hydrogel-based
microfluidics-based approaches, with the advantage of en-
abling use of stable engineered fibrous matrices.
2 Results and discussion
In the following, we first characterize the microfluidic system
and the cells with respect to E-cadherin, and then compare the
invasion of the cells into the electrospun matrices.
2.1 Design of the microfluidic system
In order to compare the invasion of the three breast cancer cell
lines (MCF-7, CAMA-1 andMDA-MB-231), we used the 3D
invasion assay developed in a previous study (Eslami
Amirabadi et al. 2017). The chip consisted of two polydimeth-
ylsiloxane (PDMS) microchannels on top of each other that
were separated by thick electrospun polycaprolactone (PCL)
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matrices in two locations (Fig. 1). The matrices had a mean
fiber diameter of 3.6 ± 0.3 μm and the matrix layers had an
average thickness of 144 ± 14 μm (Fig. s1). PCL is an excel-
lent choice of material when it comes to fabricating reproduc-
ible ECM matrices (Pham et al. 2006). We previously ob-
served that breast cancer cells were able to migrate into these
matrices and make 3D contact with the fibers. Here, like in
Transwell assays that include thin porous polymer mem-
branes, the cells move through a synthetic environment, how-
ever the three-dimensional fibrous matrix layer facilitates a
larger migration distance as well as a 3D invasion trajectories
for the cells. Furthermore, we incubated the fibrous mesh with
fibronectin overnight to enhance cell adhesion and wettability
of the fiber surface. In order to couple a perfusion system with
the chip, we glued female luer adaptors to the inlets and outlets
with viscous and semi-cured PDMS. The luers also acted as
fluidic reservoirs to seed the cells in the chip with a controlled
flow of the cell suspension. After seeding, the cells adhered to
the bottom of the upper microchannel where they started to
invade into the matrix (Fig. 1(B)). We designed a perfusion
system (Fig. s2) where the medium reservoirs, connected to
the inlets, stayed inside the incubator and a syringe pump,
outside the incubator, withdrew the liquid from the outlets of
the chips. In this way, the perfusion created a negative pres-
sure in the chip by which bubbles were removed more easily
from the fluidic circuit. The system was sealed and did not
suck in any air. In addition, we only needed to add media in
the reservoirs in order to refresh the media while the experi-
ment was running. During the experiments, the bottom
microchannels received culture medium with 10% serum
while we exposed the cells in the upper microchannel to two
conditions; in the first condition (gradient condition, Fig.
1(B)) the perfusion fed the cells with culture medium without
serum, while in the second (non-gradient condition, positive
control), it provided the cells with the medium containing
serum (complete medium). A negative control, where the star-
vation medium flows to both microchannels for up to 3 days,
would damage the cells and decrease cell viability (Fig. s3).
Experiments with Fluorescent dextran showed that the perfu-
sion system refreshed bothmicrochannels with the right media
(Fig. s4). We refreshed media in the microchannels every
100 min to stimulate cells with (different) media and at the
same time not disturb the cells with the flow. A simulation of
the concentration of growth factors in the chip is shown in Fig
s4. It shows that the gradient will cease to exist after 100 min,
if the media is not refreshed. More frequent refreshment than
each 100 min was not used because more frequent flow could
damage the cells.
After the experiments, we disconnected the chips from the
perfusion system, fixed the cells and stained them for further
analyses. At this point, we isolated the matrices with the cells
from the chip, cryo-sectioned them and determined the inva-
sion depth of the cells into the matrix using fluorescent imag-
ing. We defined the invasion depth as the distance of the cells
farthest from the top surface of the matrix (the starting point of
the invasion). Retrieving the matrices from the chips provided
the opportunity to image the invading cells with a better res-
olution than confocal microscopy. Furthermore, the cells and
the matrix are more accessible, than injectable hydrogels, for
different analytical approaches, such as secretome proteomics
or mechanical testing. Reproducibility of the synthetic matri-
ces also enables us to study the effect of different junction
proteins in repeatable way.
2.2 E-cadherin expression of breast cancer cell lines
on nanofibers and microfibers
Next, we investigated the E-cadherin expression of the
breast cancer cell lines on the electrospun matrices. We
cultured the cells on the matrices attached to PDMS
wells for 3 days. The wells enabled us to keep the cells
on the matrix at the time of seeding. To investigate
whether the cells showed the same behavior as in 2D,
we also seeded them on top of electrospun PCL
Fig. 1 (A) Microfluidic chip used in this study, introduced in
Eslami Eslami Amirabadi et al. 2017. (B) An exploded (left) and cross
sectional (right) views of the tri-layer microfluidic chip; it consists of two
microfluidic layers that are separated by thick electrospun matrices. The
matrices are integrated in the chip using a method called selective curing.
The cells are seeded on top of the matrix inside the upper (tumor)
microchannel. The cells migrate into the matrix towards the bottom
microchannel. The two microchannels are refreshed with different media
to maintain a gradient of nutrients across the matrix layer
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nanofibers (with average diameter of 300 nm, Fig. s5)
where they form a 2D monolayer. Figure 2 shows the
measured E-cadherin expression of the cells on the
nanofibrous and microfibrous matrices. As also seen in
previous studies (Kenny et al. 2007; Van De Wetering
et al. 2001), MCF-7 and CAMA-1 did express E-
cadherin on nanofibers and microfibers although this ex-
pression seems to be significantly lower in CAMA-1
than MCF-7. MDA-MB-231 cells lacked the E-cadherin
expression on both matrices. Since we have used a non-
confocal microscope for these pictures, the fluorescent
signals received from the cells on the microfibrous mesh
are weaker. The quantitative analysis in Fig. 2(B) shows
that the cells on microfibers follow a similar trend in E-
cadherin expression to the cells on the nanofibers. These
results conform with the expected behavior of E-cadherin
expression of the cells after three days of culture on the
fibrous matrices.
Fig. 2 E-cadherin expression in three breast cancer cell lines on
nanofibrous and microfibrous PCL matrices after 3 days. (A) Top view
of three breast cancer cell lines on top of electrospun PCL matrices made
of nanofibers and microfibers. The cells were stained with Dapi (cell
nucleus, blue) and E-cadherin (green). MCF-7 cells clearly express more
E-cadherin than the two other cells both on nanofibers and microfibers.
The lower intensity of E-cadherin of the cells on the microfibers is be-
cause the cells invaded into the matrix and the cell-cell contact in these
cells appeared in different planes. (B)Quantified fluorescence E-cadherin
signal from the cells on top of the electrospun matrices. The intensity of
the signal was measured and normalized by the number of the cells within
the regions of interest. All the values were then normalized to the average
intensity of E-cadherin from MCF-7 cells (relative intensity). N = 3 inde-
pendent matrices, 2 pictures were taken from each matrix. The data were
analyzed with independent sample t-test, corrected for multiple testing.
n.s.: not significant, the scale bar is 50 μm; *P < 0.05, **P < 0.01,
***P < 0.001
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2.3 Invasion of MDA-MB-231 breast cancer cells
into the electrospun matrix
We studied the invasion of MDA-MB-231 cells over time in
the gradient and positive control conditions. Throughout this
text, “invasion depth” indicates the net invasion depth of the
cells into the matrix. The serum contains nutrients for the cells
to proliferate. We seeded equal number of cells in all the
conditions and ran the experiments for 1 and 3 days.
Figure 3(A) shows the cross section of the electrospun matri-
ces. After 1 day, the cells invaded more under the serum gra-
dient than in the control (50 μm vs. 28μm, Fig. 3(B)).We saw
the same effect after 12 h in a Transwell assay (Fig. s6).
However, after 3 days, the cells invaded more in the positive
control than the gradient condition (123 μm vs. 97 μm). We
observed more cells in the sections in the positive control
which is probably because they received enough nutrients
present in the complete medium to maintain the proliferation,
whereas in the gradient condition, the cells received limited
nutrients only by diffusion from the bottom channel. Culturing
cells in the medium without serum indeed confirmed lower
cell proliferation and cell viability (Fig. s3). We speculate that
the serum gradient can drive the invasion in a short run, for
example in our case after 24 h, but at a larger time scale, e.g.
3 days, lack of nutrients hinders cancer cell proliferation and
invasion in the gradient condition. The doubling time of the
MDA-MB-231 cells is around 25 h (Mason et al. 2014) in the
normal serum condition which means that after this time, the
increased cell density enhances the invasion. Indeed higher
cell density has been reported to override other environmental
factors during the invasion ofMDA-MB-231 cells (Polacheck
et al. 2011). Conventional chemotaxis assays, such as
Transwell assay, are not able to capture this behavior since
they do not control medium content in different compartments
over time. Therefore, the current system can be a good alter-
native to the conventional assays especially where the exper-
iments require to isolate the cells and matrix from the system
without dissociation of the sample.
The MCF-7 and CAMA-1 cells did not show significant
invasion in the matrix after 1 day, and therefore only data after
3 days of invasion are reported for these cells, in the next
section. The doubling times of MCF-7 and CAMA-1 cells
are 51 and 70 h, respectively (Mason et al. 2014).
2.4 Comparing the invasion of breast cancer cell lines
with different E-cadherin status
Next, we used the microfluidic system to compare the inva-
sion ability of three breast cancer cell lines MCF-7, CAMA-1
and MDA-MB-231 in a 3D environment in the gradient and
positive control conditions. The cell lines have different E-
cadherin status and morphology (Riaz et al. 2013). MCF-7
cells grow in epithelial sheets and migrate collectively. They
are wild type for E-cadherin. CAMA-1 cells are mutant for E-
cadherin and show rounded morphology. These cells are from
the lobular type of breast cancer that invade in a multicellular
pattern as strands, cluster or Indian files(Khalil et al. 2017).
MDA-MB-231 cells have spindle-like cell morphology, lack
E-cadherin expression due to hypermethylation of the gene
promoter and usually invade as single cells. In 2D, the inva-
sion distance of all of the three cell lines have been compared
in a wound healing assay (Van Horssen et al. 2012).
Figure 3 shows the invasion of the cell lines in the gradient
condition. Highly invasive MDA-MB-231 cells had the larg-
est invasion depth. Under the serum gradient, MCF-7 cells
invaded more than CAMA-1 cells but this difference was
not significant under the positive control condition (Fig. s7).
We observed more migration in the positive control for
CAMA-1 cells compared to the gradient condition (Fig. s7),
hence showing the same behavior as MDA-MB-231 cells af-
ter 3 days (Fig. 3(B)). As mentioned before, both MDA-MB-
231 and CAMA-1 cells do not express (functional) E-
cadherin. Comparing the invasion depths of these cells sug-
gests that the mode of E-cadherin inactivation, rather than
inactive E-cadherin, is part of the events that determine the
invasiveness of the cells. In addition, invasion of MCF-7 cells
showed that E-cadherin did not suppress the invasion in this
breast cancer cell line.
The values of invasion depth in Fig. 3(C) are lower
than in two dimensional experiments (Van Horssen et al.
2012). A main reason for this difference may be that the
3D matrix presents the cells with geometrical confinement
which hinders the invasion of the cells. Also, cell adhe-
sion to 2D substrates could differ from those in our ma-
trix. However, the order of invasion is the same as what
we see in 2D, meaning that MDA-MB-231 cells invade
more than MCF-7 cells and MCF-7 cells invade more
than CAMA-1 cells. Also, the matrix remodeling, e.g.
proteolysis activity of the cells is ineffective in the syn-
thetic PCL matrix, which may be a reason for less inva-
sion of the cells compared to other 3D models with natu-
ral hydrogels as the ECM (Kumar et al. 2016; Truong
et al. 2016). The advantage of the chip used in this study
was that we could integrate matrices other than hydrogels.
i.e. engineered fibrous matrix layers, and that we were
able to retrieve the matrix from the chip intact. In future
experiments, also self-standing natural matrices can be
integrated in the microfluidic chip, such as electrospun
collagen matrices. Moreover, we compared the mode of
invasion of the three different cell lines. MDA-MB-231
cells do not express cell-cell junctions, such as E-
cadherin, and invade as single cells or as multicellular
streams without cell-cell adhesion proteins (Patsialou
et al. 2013). We found that these cells invaded the PCL
matrix as single cells in a uniform pattern independent of
the location, as shown in Fig. 4(A). CAMA-1 cells are
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mutant for E-cadherin and show rounded morphology in
2D. In addition to a diffuse growth pattern, a characteris-
tic of lobular breast cancers (Hollestelle et al. 2010), they
show a multifocal behavior (Christgen et al. 2016). When
tested inside the microfluidic chip in the 3D PCL matrix,
they mostly kept the multicellular invasion mode, mainly
as tumor nests or clusters (open arrows in Fig. 4(A)).
Interestingly, they also showed the multifocal invasion
with small cell clusters close to the invading front (arrow-
heads in Fig. 4(A)) less uniformly than MDA-MB-231
cells. MCF-7 cells are epithelial like and wild type for
E-cadherin. They mostly invade collectively in 2D and
maintain cell-cell contact during invasion (Mendoz and
Lim 2011; Planas-Silva and Waltz 2007). As seen in
Fig. 3 (A) Invasion of breast cancer cell lines into the electrospun PCL
matrices in the microfluidic chips. The cross sections show the invasion
of the cells under the gradient and positive control conditions. The cells
are seeded on top of the matrix which is the top side of the images. The
nuclei are stained with Dapi (blue). The scale bar is 50 μm. (B) Invasion
depth of breast cancer cell line MDA-MB-231 after 1 and 3 days. The
median invasion depth of the cells was 50 μm and 28 μm after 1 day and
97 μm and 123 μm after 3 days for gradient and positive control, respec-
tively. (C) Invasion depth of breast cancer cell lines MCF-7, CAMA-1
and MDA-MB-231 under the gradient after 3 days. The median invasion
depth for MCF-7, CAMA-1 and MDA-MB-231 cells was 62 μm, 44 μm
and 97 μm, respectively. The box plots divide each distribution into four
sections each containing 25% of the data. The red lines denote the me-
dians of the distribution. N ≥ 3 independent matrices from at least 2 inde-
pendent chips. 5 sections per matrix were imaged and the maximum
invasion depth of the cells at least at 5 different locations of each section
was measured (> 25 cells per matrix). Themeasured invasion depths (>75
cells per cell line per condition) were pooled together and a box plot of the
data was created. The data were analyzed with Mann-Whitney U test.
***P < 0.001, ****P < 0.0001
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Fig. 4(A), these cells migrated into the matrix mostly in a
multicellular non-uniform way.
To quantify the uniformity of invasion, we defined an in-
vasion uniformity index (Fig. 4(B)). As explained in the sec-
tion “Materials and Methods”, we measured the invasion
depth in 5 different sections of each matrix located at least
60 μm apart from each other. We calculated the standard de-
viation of invasion depth in each section and defined the in-
vasion uniformity index of the section as the inverse of this
standard deviation. The higher uniformity index for MDA-
MB-231 cells in Fig. 4(B) means that these cells invaded
through the matrix more uniformly (lower standard deviation
of invasion depth). In contrast, the lower uniformity index for
CAMA-1 and MCF-7 suggests that these cells adopted a local
non-uniform invasion pattern (higher standard deviation of
invasion depth). Non-uniform invasion seems to be connected
to the multicellular invasion. This may be because cells in
groups tend to choose larger pore sizes to invade into the
PCL matrix that has a wide distribution of pore size (see
Fig. s1). This preference decreases the number of paths
through which the cells can infiltrate into the matrix and there-
fore makes the invasion a local event.
In summary, we were able to quantitatively compare the
invasion depth and invasion mode of the cells in our
microfluidic system.
3 Materials and methods
3.1 Microfabrication methods: Electrospun matrix
and microfluidic chip
The reader is referred to the previous study for the details of
the microfabrication processes(Eslami Amirabadi et al. 2017).
Briefly, a solution of 15% Poly caprolactone (Corbion Purac
Biomaterials, the Netherlands) in 1,1,1,3,3,3-Hexafluoro-2-
propanol (HFIP, Sigma Aldrich, the Netherlands) for
microfibers and a solution of 12% PCL in Chloroform:
Methanol (5:1) for nanofibers was made. These were
electrospun using an EC-CLI electrospinning apparatus,
IME Technologies, to obtain fibrous matrix layers with aver-
age thickness of 144 ± 14 μm. Occasionally, random spikes of
fibers come out of the fibrous mesh which locally increases
the thickness of the mesh. However, as shown in Fig. s1(C),
Fig. 4 (A) Invasion of breast cancer cell lines into the electrospun PCL
matrices inside the microfluidic chip. The cross sections show the
invading cells under the positive control condition after 3 days. The
cells (green) were seeded on top of the matrix which is the top side of
the images. The cells invaded into the matrix individually (MDA-MB-
231) or in clusters (CAMA-1 and MCF-7). The open arrows show the
clusters of CAMA-1 cells, and the arrow heads show smaller cell clusters
near the invading front line indicating the multifocal behavior of the cells.
The white dashed lines show the invading front of the invading cells,
indicating how uniform the cells invade to the matrix. The cells were
stained with Phalloidin Atto 488 (cytoskeleton). The scale bar is
50 μm. (B) The invasion uniformity index, defined as the inverse of
standard deviation of the invasion depths measured in each section of
the matrix. Higher uniformity index corresponds to a more uniform inva-
sion pattern. MDA-MB-231 cells invaded to the matrix uniformly across
the matrix and therefore had higher invasion uniformity index, with a
median of 0.1153 μm−1 and 0.1040 μm−1 for 1 day and 3 days, respec-
tively. On the other hand, CAMA-1 and MCF-7 cells invaded to the
matrix in a non-uniform way. Median invasion depths for CAMA-1 and
MCF-7 cells are 0.0692 μm−1 and 0.0561 μm−1, respectively. N ≥ 3 in-
dependent matrices from at least 2 independent chips. The data were
analyzed with Mann-Whitney U test. *P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001, n.s. indicates no significance. The arrows and
numbers on top of the graphs demonstrate the number of outliers outside
the range of the y axis
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these are usually outliers and therefore do not affect the re-
sults. For fiber thickness distribution, we chose 5 images per
condition and measured the average thickness of the fibrous
mesh in each image. The average diameter of the microfibers
and nanofibers were 3.6 μm and 300 nm, respectively.
For evaluating E-cadherin expression on the microfibers
and nanofibers, blank PDMS (Sylgrad 184, Dow corning,
Germany) was partially cured at the ratio of 1:10. Cubes of
approximately 10*10*4 mm were cut out and punched with
an 8 mm puncher (PDMS well). Matrices, either nanofibrous
or microfibrous, were cut to approximately 8*8 mm and
sandwiched between two PDMSwells. The sandwich was left
at room temperature to cure completely.
The microfluidic chip consisted of two layers of
microchannels made of PDMS with two PCL electrospun ma-
trices in between, as seen in Fig. 1. Soft lithography was used
to make the microchannels. The microchannels were approx-
imately 400 μm high, 2.5 mm wide and 25 mm long. The
matrices were integrated in the chip using a method called
selective curing (Eslami Amirabadi et al. 2017). Briefly, liquid
PDMS without curing agent was spin-coated on a microscope
slide and two pieces of the matrix were applied in the PDMS
film on the microscope slide. PDMS with curing agent (ratio
of 1:10) with the microchannel features was partially cured
and aligned with the matrices and gently left on the micro-
scope slides. The assembly was left overnight to cure
completely at room temperature. A second PDMS layer was
partially cured and bonded to the first layer with the same
method. Now, the PDMS without curing agent inside the ma-
trix was cured, by diffusion of curing agent from the
microchannel layers, everywhere except where the
microchannels crossed each other since the matrix did not
make contact with PDMS parts at that location. PDMS in this
location was subsequently removed by flushing the chip with
Isopropanol two times with a time difference of at least 4 h.
The chip was then washed with distilled water.
Using our previous publication (Eslami Amirabadi et al.
2017), we assumed that the diffusion coefficient of small
growth factors (such as EGF) is Dmatrix = 0.1 × Dwater, where
Dwater is the diffusion coefficient of the growth factors in an
aqueous solution or medium. COMSOL multiphysics was
used to simulate the diffusion of the growth factors inside
the matrix, see Fig. s4. For simplicity, a concentration of
0 mol/m3 and 1 mol/m3 were assumed in the top and bottom
microchannels, respectively. Changing the concentration in
the chip does not change the diffusion profile in time.
3.2 Preparation of the microfluidic chips
PBS (Lonza, Westburg, the Netherlands) was injected into the
chips and the chips were degassed for 15–30 min. New PBS
was injected into the chips to completely fill the
microchannels and the luer connections acting as reservoirs
near the inlets and outlets. All surfaces of the chips were
sterilized with 70% ethanol (v/v). The liquid exchange inside
the microchannels was generated by a height difference be-
tween inlets and outlets. After washing the ethanol with PBS,
the microchannels as well as the electrospun matrix were coat-
ed with 50 μg/ml fibronectin (Merck Chemicals, the
Netherlands) in PBS overnight at 37 °C. The fibronectin so-
lution was subsequently replaced by starvation medium.
3.3 General cell culturing
MDA-MB-231 and CAMA-1 breast cancer cell lines are de-
scribed in Hollestelle et al.(Hollestelle et al. 2007). MCF-7
cells were purchased from Sigma Aldrich, the Netherlands.
The cell lines were maintained and expanded in RPMI-1640
Glutamax medium (Gibco, Thermofisher Scientific,
The Netherlands) supplemented with 10% (v/v) foetal bovine
serum (FBS, Bovogen Biologicals, Australia and Lonza,
Breda, the Netherlands) and 1% Penicillin-Streptomycin
(P/S, Lonza, Westburg, the Netherlands). The starvation me-
dium used was RPMI-1640 Glutamax medium (Gibco,
Thermofisher Scientific, The Netherlands) supplemented with
0.1% (w/v) bovine serum albumin (BSA, Roche diagnostics,
Indianapolis, USA) and 1% P/S (Lonza, Westburg, the
Netherlands). In 70% to 90% confluency, the cells were re-
moved from the surface by trypsin EDTA (Lonza, Westburg,
the Netherlands), centrifuged at 900 rpm for 5 min, and resus-
pended in either normal (to culture in a flask) or starvation
medium (to seed the chips).
To test the expression of E-cadherin on the nanofibrous and
microfibrous matrices, these matrices were first sterilized with
70% ethanol in water, washed with PBS and then coated with
50μg/ml fibronectin (MerckMillipore, the Netherlands) over-
night in a wells plate. After removing the fibronectin, the wells
and the matrices were hydrated in PBS and saved in a fridge
for cell culturing. 20μl of the cell suspension with a density of
6 × 106 cells/ml was put on the matrices. After 2 h, the cells
were supplied with fresh medium and maintained at 37 °C and
5% CO2 for 4 days.
To test the viability of the cells with the normal and starva-
tion media, we seeded 0.2 × 106 cells/ml to a 12-wells plate
with the two media and maintained the culture at 37 °C and
5% CO2 for 3 days.
3.4 Invasion assay
The cells were starved with the starvation medium overnight.
After removing from the surface and centrifuging, the cells
were resuspended in the starvation medium. They were then
counted using NucleoCounter NC200 (Chemometec,
Denmark) and diluted to obtain a concentration of ~ 8.5 ×
106 cells/ml. The reservoirs were filled with medium, and
the ones connected to the inlet and outlet of the bottom
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microchannels were blocked using luer plugs. The other res-
ervoirs were then emptied. 100 μl of the cell suspension was
added to the inlet of the upper microchannel to create a flow to
the outlet. After at least 4 h of incubation, the chips were
connected to the perfusion system to automatically refresh
the media (Fig. s2). Refreshing the medium is necessary for
creating and maintaining the chemotactic gradient. A syringe
pump (Nexus 3000, Chemyx, Texas, USA) was used for this
purpose. A gentle flow (50 μl/min) was created for 1 min
every 100 min. As shown in Eslami Amirabadi et al. 2017
and Fig. s4, this refreshes the gradient while not disturbing
cells with the shear stress from the flow. Both microchannels
of the control chips were refreshed with normal medium. The
top and bottom microchannels of the chemotaxis chip were
refreshed with starvation and normal medium, respectively.
For the Transwell invasion assay, the wells and inserts, in a
24 well format with a pore size of 8 mm (Corning Transwell,
Sigma Aldrich the Netherlands), were coated with 50 μg/ml
fibronectin overnight. Normal medium was added to all the
wells. The cells were resuspended in the normal (for positive
control) and starvation (for gradient) media and 100 μl of
approximately 1 × 106 cells/ml cell suspension was added to
the inserts. The experiments lasted 12 h.
3.5 Staining and cryosectioning
After running the invasion assays, the cells were fixated using
3.7% paraformaldehyde (Sigma Aldrich, the Netherlands) for
30 min. The matrices were isolated from the chips and washed
with 0.5% Triton X-100 for 15 min, after which they were
washed with PBS. The cells were stained with DAPI (1:500
dilution, Sigma Aldrich, the Netherlands) and Phalloidin Atto
488 (Sigma Aldrich, the Netherlands) to visualize the nuclei
and the actin cytoskeleton of the cells, respectively.
The stained matrices were embedded in TissueTEK
(Sakura Finetek, the Netherlands). To freeze the samples,
10 ml Iso-pentane (Merck Chemicals, the Netherlands) was
added to a beaker and was left on dry ice or liquid nitrogen for
at least 5 min to ensure Iso-pentane was cooled down. Then,
the samples were placed in the beaker until it was completely
frozen. The samples were stored for at most one week at
−30 °C. Using a cryotome (Microm HM550 cryostat micro-
tome, Thermo Scientific, the Netherlands) sections with a
thickness of 20 μm were made at −20 °C and attached to
microscope slides (Polysine slides, Thermo Scientific, the
Netherlands). This protocol was optimized for sectioning
quality, minimal deformation and motion of matrix fibers
and cells, see (Eslami Amirabadi et al. 2017).
For the visualization of the E-cadherin in the cells on both
nanofibers and microfibers, the cells were fixed using 3.7%
paraformaldehyde (Sigma Aldrich, the Netherlands), perme-
abilized with 0.5% Triton X-100 for 10 min and subsequently
washed with PBS. Then, the constructs were blocked using
4% goat serum in 0.05% Tween-PBS for 30 min, after which
E-cadherin monoclonal primary antibody (HECD-1, 5 μg/ml,
Thermofisher Scientific, the Netherlands) was incubated over-
night at 4 °C. The next day, the matrices were washed with
PBS and a secondory antibody (1:500 dilution, Alexa Fluor
488 goat anti-mouse IgG1, Thermofisher Scientific, the
Netherlands) was added to the samples for 1 h. In order to
relate the expression to the amount of cells present, the cells
were again stained with DAPI (1:500 dilution, Sigma Aldrich,
the Netherlands)).
Viability of the cells was tested using the ReadyProbes cell
viability imaging kit (Life Technologies, USA). Viability was
tested after 3 days of culturing cells in the normal and starva-
tion media in a wells plate. 2 drops of each probe were added
to 1 ml of medium and then added to the wells. The cells were
incubated for 15 min and then imaged for blue (alive) and
green (dead) with an EVOS FL cell imaging microscope
(ThermoFisher scientific, the Netherlands).
3.6 Microscopy
The fluorescent imaging of the E-cadherin expression and
invasion was performed with a Zeiss LSM510 META NLO
(Zeiss Nederland, the Netherlands) with a 20x objective. PCL
is autofluorescent with low intensities in all wavelengths. No
fluorescence filter was used to visualize the Autofluorescence
of the PCL matrix in order to have an indication of the bound-
aries of the matrix. 5 sections per matrix, at least 60 μm apart,
were imaged.
To generate a tiled image, the mosaic function of a Zeiss
Axiovert 200 M microscope with a blue filter (Dapi staining)
with a 10x objective was used to image the cells attached to
the membrane of the Transwell inserts.
3.7 Data analysis
All images were analyzed using ImageJ. The data for each
category (per cell line and per condition) was obtained from
more than three independent matrices from at least two inde-
pendent chips. Five sections per matrix were imaged and the
maximum invasion depth of the cells at least at 5 different
locations of each section was measured (more than 25 cells
per matrix). The measured invasion depths (more than 75 cells
per cell line per condition) were pooled together and a box plot
of the data was created. Matlab was used to plot all the data
and the Mann-Whitney U test was used to assess the statistical
significance of the differences between the data.
To quantify E-cadherin, 3 independent experiments were
done. From each matrix, at least 2 sets of pictures were made
from different locations. Each set of pictures contained at least
one image of the E-cadherin antibody staining and one image
of DAPI staining of the exact same location. The intensity of
E-cadherin staining was measured and normalized to the
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amount of cells present. An independent sample T-test with
Bonferroni correction was used to assess the statistical differ-
ence in the intensity of the E-cadherin staining.
4 Conclusion
We used a previously developed microfabrication method to
realize a microfluidic system that we applied to quantitatively
study the invasion ability and invasion mode of breast cancer
cells, with different E-cadherin status, while they invaded into
an engineered 3D fibrous matrix under a controlled serum
gradient. We cultured MCF-7 with epithelial-like, CAMA-1
with rounded (lobular) and highly invasive MDA-MB-231
cells with mesenchymal phenotype inside the microfluidic
chip. We confirmed that MDA-MB-231 cells did not express
E-cadherin on the matrix while the two other cell lines
expressed E-cadherin although in different levels. We saw that
in 3 days, MDA-MB-231 cells invaded deeper into the 3D
matrix than the other two cell lines in a serum gradient.
Also, both CAMA-1 and MCF-7 showed a multicellular in-
vasion pattern while MDA-MB-231 cells invaded as single
cells. We were able to capture the multicellular multifocal
and multicellular collective behavior of the infiltrating
CAMA-1 and MCF-7 cells, respectively. Moreover, we found
that MDA-MB-231 cells invaded more in the presence of the
gradient after 1 day, but migrated more after 3 days when they
were supplied enough serum in the medium in both
microchannels.
The results show that our microfluidic system enables the
quantitative analysis of three-dimensional cancer cell invasion
in an engineered 3Dmatrix while maintaining stable biochem-
ical conditions, which forms a major step compared to 2D
methods like Transwell of wound healing assays. Also, our
study underlines that our microfluidic system provides an al-
ternative to current microfluidic models for cancer invasion
under a controlled gradient. First, the chip enables us to use
other ECM models than hydrogels which offer limited possi-
bilities to create a well-controlled fibrous matrix structure,
with a characteristic of the engineered synthetic PCL matrix
layer. Second, the fabrication method allows us to retrieve the
tested matrix from the chip without cell or matrix dissociation.
This feature opens up the possibility to utilize a diversity of
analytical read-outs, such as proteomic approaches or me-
chanical measurements. The current investigation was a proof
of concept to study the non-proteolytic invasion of cancer
cells, using engineered fibrous PCL as a synthetic 3D matrix,
hence the biological context of the extracellular matrix is par-
tially not captured in the results presented. Integration of nat-
ural matrices in the chip, for example decellularized or
electrospun collagen matrices (Sell et al. 2010), in the future
will allow us to compare the invasion ability and invasion
mode of the cells when matrix remodeling by proteolysis is
present. Furthermore, other elements of the TME can be added
to the chip to understand their effect on cancer invasion. For
example, fibroblasts or endothelial cells can be cultured on the
bottom side of the matrix to study how these cells affect cancer
cell invasion speed or directionality. Finally, the effect of cell
treatments on their invasion potential can be quantitatively
assessed in the future.
Acknowledgments The authors would like to thank prof. Carlijn Bouten
from the department of Biomedical Engineering at TU/e for the use of the
knowledge and equipment in the cell and tissue lab at TU/e. We would
like to thank Andrea di Luca and Paul Miggiels for the electrospinning
protocols, and Dr. Moniek de Liefde-van Beest, ing. Willie ter Elst and
Dr. Marloes Janssen-van de Broek for their support in the laboratory. We
thank Dr. Yolande Ramos for her valuable advice. This research is em-
bedded in theOrgan onChipConsortium hDMT, and it is partially funded
by the Technology Foundation STW.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
G. Berx, F. van Roy, Cold spring Harb. Perspect. Biol. 1 (2009)
K.J. Cheung, A.J. Ewald, Curr. Opin. Cell Biol. 30, 99 (2014)
M. Christgen, D. Steinemann, E. Kühnle, F. Länger, O. Gluz, N. Harbeck,
H. Kreipe, Pathol. Res. Pract. 212, 583 (2016)
H. Eslami Amirabadi, S. SahebAli, J.P. Frimat, R. Luttge, J.M.J. den
Toonder, Biomed. Microdevices 19, 92 (2017)
Ferlay J, Soerjomataram I, ErvikM, Dikshit R, Eser S,Mathers C, Rebelo
M, Parkin DM, Forman D, Bray F, Lyon, Fr. Int. Agency Res.
Cancer; 2013. Available from Http//Globocan.Iarc.Fr (2012)
P. Friedl, S. Alexander, Cell 147, 992 (2011)
P. Friedl, D. Gilmour, Nat. Rev. Mol. Cell Biol. 10, 445 (2009)
J.R. Graff, J.G. Herman, R.G. Lapidus, H. Chopra, R. Xu, D.F. Jarrard,
W.B. Isaacs, P.M. Pitha, N.E. Davidson, S.B. Baylin, Cancer Res.
55, 5195 (1995)
A. Hollestelle, F. Elstrodt, J.H.A. Nagel, W.W. Kallemeijn, M. Schutte,
Mol. Cancer Res. 5, 195 (2007)
A. Hollestelle, F. Elstrodt, M. Timmermans, A.M. Sieuwerts, J.G.M.
Klijn, J.A. Foekens, M.A. Den Bakker, M. Schutte, Breast Cancer
Res. Treat. 122, 125 (2010)
A. Hollestelle, J.K. Peeters, M. Smid, M. Timmermans, L.C. Verhoog,
P.J. Westenend, A.A.J. Heine, A. Chan, A.M. Sieuwerts, E.A.C.
Wiemer, J.G.M. Klijn, P.J. Van Der Spek, J.A. Foekens, M.
Schutte, M.A. Den Bakker, J.W.M. Martens, Breast Cancer Res.
Treat. 138, 47 (2013)
R. Van Horssen, A. Hollestelle, J.A.P.R. Rens, A.M.M. Eggermont, M.
Schutte, T.L.M. Ten Hagen, Breast Cancer Res. Treat. 136, 365
(2012)
C. Justus, N. Leffler, M. Ruiz-Echevarria, L. Yang, J. Vis. Exp. 88, 1
(2014)
P.A. Kenny, G.Y. Lee, C.A. Myers, R.M. Neve, J.R. Semeiks, P.T.
Spellman, K. Lorenz, E.H. Lee, M.H. Barcellos-Hoff, O.W.
Petersen, J.W. Gray, M.J. Bissell, Mol. Oncol. 1, 84 (2007)
  101 Page 10 of 11 Biomed Microdevices          (2019) 21:101 
A.A. Khalil, O. Ilina, P.G. Gritsenko, P. Bult, P.N. Span, P. Friedl, Clin.
Exp. Metastasis 34, 421 (2017)
S. Kumar, A. Kapoor, S. Desai, M.M. Inamdar, S. Sen, Sci. Rep. 6, 1
(2016)
M. Lombaerts, T. van Wezel, K. Philippo, J.W.F. Dierssen, R.M.E.
Zimmerman, J. Oosting, R. van Eijk, P.H. Eilers, B. van de Water,
C.J. Cornelisse, A.-M. Cleton-Jansen, Br. J. Cancer 94, 661 (2006)
J.M. Mason, D.C.C. Lin, X. Wei, Y. Che, Y. Yao, R. Kiarash, D.W.
Cescon, G.C. Fletcher, D.E. Awrey, M.R. Bray, G. Pan, T.W. Mak,
Cancer Cell 26, 163 (2014)
E. Mendoz, C.T. Lim, Cell. Mol. Bioeng. 4, 411 (2011)
A. Patsialou, J.J. Bravo-Cordero, Y. Wang, D. Entenberg, H. Liu, M.
Clarke, J.S. Condeelis, IntraVital 2, e25294 (2013)
Q.P. Pham, U. Sharma, A.G. Mikos, Biomacromolecules 7, 2796 (2006)
M.D. Planas-Silva, P.K. Waltz, J. Steroid Biochem. Mol. Biol. 104, 11
(2007)
W.J. Polacheck, J.L. Charest, R.D. Kamm, Proc. Natl. Acad. Sci. U. S. A.
108, 11115 (2011)
W.J. Polacheck, I.K. Zervantonakis, R.D. Kamm, Cell. Mol. Life Sci. 70,
1335 (2013)
D.F. Quail, J.A. Joyce, Nat. Med. 19, 1423 (2013)
M. Riaz,M.T. van Jaarsveld, A. Hollestelle, W.J. Prager-van der Smissen,
A.A. Heine, A.W. Boersma, J. Liu, J. Helmijr, B. Ozturk, M. Smid,
E.A. Wiemer, J.A. Foekens, J.W. Martens, Breast Cancer Res. 15,
R33 (2013)
F.J. Rodriguez, L.J. Lewis-Tuffin, P.Z. Anastasiadis, Biochim. Biophys.
Acta - Rev. Cancer 1826, 23 (2012)
E.T. Roussos, J.S. Condeelis, A. Patsialou, Nat. Rev. Cancer 11, 573
(2011)
S.A. Sell, P.S. Wolfe, K. Garg, J.M. McCool, I.A. Rodriguez, G.L.
Bowlin, Polymers (Basel) 2, 522 (2010)
J.J.F. Sleeboom, H. Eslami Amirabadi, P. Nair, C.M. Sahlgren, J.M.J. den
Toonder, Dis. Model. Mech. 11, dmm033100 (2018)
D. Truong, J. Puleo, A. Llave, G. Mouneimne, R.D. Kamm, M. Nikkhah,
Sci. Rep. 6, 34094 (2016)
M. Van De Wetering, N. Barker, I.C. Harkes, M. Van Der Heyden, N.J.
Dijk, A. Hollesteue, J.G.M. Klijn, H. Clevers, M. Schutte, Cancer
Res. 61, 278 (2001)
J. Wu, X. Wu, F. Lin, Lab Chip 13, 2484 (2013)
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Biomed Microdevices          (2019) 21:101 Page 11 of 11   101 
